Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Levosimendan in Patients With Acute Decompensated Heart Failure: A Real-World Evidence

NCT07262723 is registered in ClinicalTrials.gov with Chittagong Medical College as lead sponsor.

NCT NCT07262723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07262723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Levosimendan in Patients With Acute Decompensated Heart Failure: A Real-World Evidence
Lead sponsor
Chittagong Medical College
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
December 30, 2026
Enrollment
332 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure (adhf)